Erdafitinib
A small-molecule FGFR (fibroblast growth factor receptor) kinase inhibitor that blocks signaling pathways some tumors rely on for growth. It is a prescription oncology drug approved for certain FGFR-altered urothelial (bladder) cancers.
- Sources carrying it
- 5
- Listings indexed
- 7
- Lowest listed
- $124.69
- Median
- $240.00
- Highest listed
- $35,000.00
across 4mg → 500000mg
Sticker prices in US dollars, across every dosage and pack size (4mg → 500000mg) — so the spread includes different quantities, not just different sellers. Prices are the sellers' own listed prices, re-checked periodically rather than tracked daily.
Who lists it & for how much
Members only
The 5 sources that list Erdafitinib, and what each one charges, are behind the membership. Prices above are the range across every source that lists it — the membership is what tells you which source and for how much, with links and contacts.
Already a member? Sign in
Other raw powders indexed
- RU58841from $22.80
- Phenibutfrom $9.00
- DMAAfrom $17.00
- Fladrafinilfrom $23.00
- DNPfrom $60.00
- Fonturacetam Hydrazidefrom $20.00
- Phenylpiracetamfrom $29.99
- ATX-304from $49.99
- DADAfrom $28.00
- Epinephrinefrom $2.36
- Sulbutiaminefrom $19.99
- Caffeinefrom $2.25
Sourcery is an information directory. It does not sell anything and does not handle orders — it indexes what sources publish so they can be compared in one place.